U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07902375) titled 'Methylation Profiling in Self-samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers' on Oct. 21.
Brief Summary: The goal of the MYSSELF study is to investigate which biological markers (i.e., (epi)genetic biomarkers) found in self-collected samples, such as first-void urine and vaginal samples, are linked to the presence of endometrial, ovarian, vulvar, or vaginal (pre-)cancer or to postmenopausal bleeding. Samples collected by clinicians from the cervix or vulva, as well as blood and tissue samples, will be used for comparison. The study will explore whether these markers could help improve earlier and les...